LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -15.09%-157.37M | 16.49%-31.11M | 33.41%-33.26M | -191.29%-53.72M | -26.31%-39.28M | -14.25%-136.73M | -49.37%-37.26M | -64.48%-49.94M | 25.23%-18.44M | 21.70%-31.09M |
Net income from continuing operations | -559.54%-187.12M | -31.12%-40.22M | 38.51%-38.14M | -1,363.37%-54.05M | -142.38%-54.72M | 127.29%40.72M | -12.73%-30.67M | -55.63%-62.02M | 108.97%4.28M | 474.96%129.14M |
Operating gains losses | 97.17%-5.68M | 159.19%22.08M | -274.38%-25.46M | 114.39%5.84M | 95.55%-8.14M | -3,294.20%-200.53M | 468.69%8.52M | 377.97%14.6M | -1,148.32%-40.59M | -3,071.74%-183.06M |
Depreciation and amortization | 10.93%6.16M | 30.28%1.76M | 22.39%1.56M | 20.26%1.4M | -18.41%1.44M | 27.81%5.55M | 18.56%1.35M | 15.00%1.27M | 3.46%1.17M | 81.63%1.76M |
Change In working capital | 42.18%-13.04M | 1.16%-25.89M | 225.09%17.94M | -359.33%-17.7M | 13.10%12.61M | -5.50%-22.55M | -187.61%-26.19M | -523.23%-14.34M | -7.49%6.83M | 148.41%11.15M |
-Change in receivables | -730.01%-166.22M | -269.45%-210.51M | 193.00%7.35M | -118.23%-6.55M | 387.30%43.5M | 28.35%-20.03M | -70.85%-56.98M | -97.85%-7.9M | 159.42%35.93M | 300.36%8.93M |
-Change in prepaid assets | 58.85%-3.48M | -60.05%1.83M | 149.02%804K | 37.10%-3.56M | 55.50%-2.56M | -19.74%-8.46M | 2,093.91%4.59M | -187.05%-1.64M | -468.07%-5.66M | 25.57%-5.75M |
-Change in payables and accrued expense | -88.64%2.29M | -33.23%10.29M | 905.32%10.77M | 111.91%1.97M | -202.69%-20.75M | 216.59%20.12M | 355.12%15.42M | -78.22%1.07M | -568.08%-16.57M | 468.06%20.2M |
-Change in other current assets | 15.14%8.94M | -49.71%1.03M | 85.26%3.71M | -44.81%2.05M | --2.15M | 6.57%7.77M | -17.41%2.04M | 19.74%2M | 93.85%3.72M | --0 |
-Change in other current liabilities | -172.14%-10.05M | -107.25%-2.32M | -281.17%-3.79M | -106.66%-1.99M | -215.73%-1.97M | -294.42%-3.69M | -213.98%-1.12M | -278.60%-993K | -668.80%-961K | -227.40%-623K |
-Change in other working capital | 951.69%155.48M | 1,662.88%173.79M | 86.83%-906K | -0.02%-9.63M | 33.11%-7.76M | -859.33%-18.26M | -44.09%9.86M | -317.42%-6.88M | 10.88%-9.63M | -63.91%-11.6M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -15.09%-157.37M | 16.49%-31.11M | 33.41%-33.26M | -191.29%-53.72M | -26.31%-39.28M | -14.25%-136.73M | -49.37%-37.26M | -64.48%-49.94M | 25.23%-18.44M | 21.70%-31.09M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -22.90%148.84M | 139.38%23.48M | 587.00%90.7M | -56.01%29.58M | -97.05%5.08M | 114.43%193.03M | -615.83%-59.61M | 68.41%13.2M | 95.92%67.24M | 374.33%172.2M |
Net PPE purchase and sale | 45.45%-7.31M | 64.78%-873K | 72.71%-1.34M | 58.76%-1M | -14.39%-4.1M | -67.24%-13.4M | -84.18%-2.48M | -64.01%-4.92M | -22.95%-2.43M | -111.08%-3.58M |
Net business purchase and sale | 1,208.51%45.73M | ---72K | --48.8M | ---3M | --0 | 41.30%-4.13M | --0 | --0 | --0 | 35.82%-4.13M |
Net investment purchase and sale | 74.31%110.42M | 142.68%24.42M | 138.93%43.25M | -0.89%33.58M | -86.62%9.17M | -32.06%63.35M | -543.40%-57.21M | 66.97%18.1M | 35.16%33.88M | 54.36%68.58M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -22.90%148.84M | 139.38%23.48M | 587.00%90.7M | -56.01%29.58M | -97.05%5.08M | 114.43%193.03M | -615.83%-59.61M | 68.41%13.2M | 95.92%67.24M | 374.33%172.2M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 11.88%10.12M | -94.89%119K | -70.53%392K | -64.48%1.61M | 823.30%8.01M | 328.82%9.05M | 382.78%2.33M | 310.49%1.33M | 1,042.42%4.52M | -4.52%867K |
Net issuance payments of debt | -205.26%-58K | -7.14%-15K | -180.00%-14K | ---15K | ---14K | ---19K | ---14K | ---5K | --0 | --0 |
Net common stock issuance | --8.87M | --177K | --0 | --1.06M | --7.63M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | -84.22%1.49M | -94.28%134K | -73.53%406K | -88.12%558K | -54.79%392K | 347.39%9.44M | 385.68%2.34M | 373.46%1.53M | 1,086.36%4.7M | -4.52%867K |
Net other financing activities | 52.55%-177K | ---- | ---- | ---- | ---- | ---373K | --0 | ---199K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 11.88%10.12M | -94.89%119K | -70.53%392K | -64.48%1.61M | 823.30%8.01M | 328.82%9.05M | 382.78%2.33M | 310.49%1.33M | 1,042.42%4.52M | -4.52%867K |
Net cash flow | ||||||||||
Beginning cash position | 68.27%161.07M | -33.42%170.18M | -61.40%112.34M | -43.26%134.87M | 68.27%161.07M | -22.35%95.72M | 135.32%255.61M | 122.46%291.02M | 96.82%237.69M | -22.35%95.72M |
Current changes in cash | -97.57%1.59M | 92.05%-7.52M | 263.35%57.84M | -142.27%-22.54M | -118.45%-26.19M | 337.20%65.35M | -632.71%-94.54M | -59.50%-35.41M | 430.53%53.32M | 5,781.27%141.98M |
End cash Position | 0.99%162.66M | 0.99%162.66M | -33.42%170.18M | -61.40%112.34M | -43.26%134.87M | 68.27%161.07M | 68.27%161.07M | 135.32%255.61M | 122.46%291.02M | 96.82%237.69M |
Free cash flow | -9.69%-164.68M | 19.50%-31.99M | 36.93%-34.6M | -162.21%-54.72M | -25.08%-43.37M | -17.57%-150.14M | -51.15%-39.73M | -64.44%-54.86M | 21.66%-20.87M | 16.26%-34.67M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |